Exosomes from human umbilical cord mesenchymal stem cells promote the growth of human hair dermal papilla cells.
Yu-Cheng Chen, Wei-Cheng Tsai, Zhi-Xiang Li...
https://pubmed.ncbi.nlm.nih.gov/40305498/Actively Recruiting
Led by Chang Gung Memorial Hospital · Updated on 2026-10-22
30
Participants Needed
1
Research Sites
4 weeks
Total Duration
Researchers are studying the use of fractional laser combined with topical exosome treatment to assess hair regrowth in men with androgenetic alopecia, a common form of male pattern baldness. This trial aims to evaluate the safety, tolerability, and effectiveness of this combined treatment approach. The study will enroll 30 male participants aged 18 to 50 years diagnosed with Norwood-Hamilton classification III-V male pattern baldness. Participants will receive three monthly fractional laser treatments on their scalp. The study uses a split-scalp design where one side of the scalp is treated with human umbilical cord mesenchymal stem cell exosome solution applied twice daily, while the other side receives a placebo saline solution on the same schedule. This treatment phase lasts for three months, followed by an additional three months where only the topical exosome or placebo is applied twice daily without laser treatment. Throughout the six-month study, participants will be monitored regularly. Hair density, hair diameter, the ratio of vellus to terminal hair, and any adverse reactions will be measured using trichotomy and standardized photographic assessments. The primary outcome is the change in hair density at day 84, with further evaluations of hair characteristics and global photographic results at day 168. The trial includes safety monitoring and adherence to treatment guidelines, with total participation lasting six months.
CONDITIONS
A Split-Scalp Study Evaluating the Efficacy and Safety of Fractional Laser Therapy With and Without Exosomes in the Treatment of Androgenetic Alopecia
C
Chun-Yu Cheng, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Chang Gung Memorial Hospital
Lead Sponsor
ExoOne bio
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 3 months
Participants receive monthly fractional laser treatments for three months. During this time, one side of the scalp is treated twice daily with exosome solution, and the other side with placebo saline solution.
3 visits (once per month)
Duration - 3 months
Participants apply exosome solution to one side of the scalp twice daily and placebo saline to the other side twice daily for three months without laser treatments.
Regular follow-up visits for assessments
Duration - 6 months total
Participants are monitored for hair growth changes and any side effects using imaging and trichotomy assessments over the total six months.
Periodic visits throughout the study
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Yu-Cheng Chen, Wei-Cheng Tsai, Zhi-Xiang Li...
https://pubmed.ncbi.nlm.nih.gov/40305498/Farahnaz Amini, Jing Ju Teh, Chung Keat Tan...
https://pubmed.ncbi.nlm.nih.gov/40141845/Poonkiat Suchonwanit, Salinee Rojhirunsakool, Saranya Khunkhet
https://pubmed.ncbi.nlm.nih.gov/30982177/Chang Gung Memorial Hospital
Lead Sponsor
ExoOne bio
Collaborating Sponsor